NCT01034787
- Conditions
- Eye Diseases, Eye Neoplasms, Melanoma, +15 more
- Locations
-
- Tom Baker Cancer Centre Calgary, Alberta, Canada
- Cross Cancer Institute Edmonton, Alberta, Canada
- Princess Margaret Hospital Toronto, Ontario, Canada
Clinical trial condition
Neuroendocrine Tumors
Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.
2,768 public trials
494 recruiting studies
Neuroendocrine Tumors trial results
Completed
Treatment of Unresecable and/or Metastatic Merkel Cell Carcinoma by Somatostatine Analogues
NCT02351128
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +13 more
- Locations
-
- Grenoble University Hospital Grenoble, France
NCT03057327
- Conditions
- Melanoma, Melanoma (Skin Cancer), Neoplasms, +10 more
- Locations
-
- Northwestern Memorial Hospital Chicago, Illinois, United States
Completed
Comparison Between Posterior Retroperitoneoscopic Adrenalectomy and Laparoscopic Adrenalectomy
NCT01676025
- Conditions
- Adrenal Disease, Adrenal Gland Diseases, Adrenal incidentaloma, +12 more
- Locations
-
- Seoul National University Hospital Seoul, South Korea
NCT03165409
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- Bristol-Myers Squibb Princeton, New Jersey, United States
NCT01227889
- Conditions
- Cancer, Melanoma, Neoplasms, +10 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Mobile, Alabama, United States
- GSK Investigational Site La Jolla, California, United States
- GSK Investigational Site Los Angeles, California, United States
Completed
Combination of Decitabine and Temozolomide in the Treatment of Patients With Metastatic Melanoma
NCT00715793
- Conditions
- Malignant Melanoma, Melanoma, Neoplasm Metastasis, +14 more
- Locations
-
- UPMC Cancer Centers Pittsburgh, Pennsylvania, United States
NCT01153763
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site San Francisco, California, United States
- GSK Investigational Site Philadelphia, Pennsylvania, United States
NCT02574533
- Conditions
- Malignant Melanoma, Melanoma, Melanoma Recurrent, +11 more
- Locations
-
- Texas Oncology P.A., Texas Cancer Center Abilene, Texas, United States
- Mary Crowley Medical Research Centers Dallas, Texas, United States
- Cancer Care Northwest Spokane, Washington, United States
NCT00390338
- Conditions
- Melanoma, Melanoma (Skin), Neoplasms, +10 more
- Locations
-
- UPMC Cancer Center at Magee-Womens Hospital Pittsburgh, Pennsylvania, United States
- UPMC Cancer Centers Pittsburgh, Pennsylvania, United States